The expanding role of prodrugs in contemporary drug design and development

@article{Rautio2018TheER,
  title={The expanding role of prodrugs in contemporary drug design and development},
  author={Jarkko Rautio and Nicholas A Meanwell and Li Ping Di and Michael J. Hageman},
  journal={Nature Reviews Drug Discovery},
  year={2018},
  volume={17},
  pages={559-587}
}
Prodrugs are molecules with little or no pharmacological activity that are converted to the active parent drug in vivo by enzymatic or chemical reactions or by a combination of the two. Prodrugs have evolved from being serendipitously discovered or used as a salvage effort to being intentionally designed. Such efforts can avoid drug development challenges that limit formulation options or result in unacceptable biopharmaceutical or pharmacokinetic performance, or poor targeting. In the past 10… CONTINUE READING
85
Twitter Mentions

Figures, Tables, and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 266 REFERENCES

177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer

Axel Bräuer, Lena Sophie Grubert, +4 authors Kambiz Rahbar
  • European Journal of Nuclear Medicine and Molecular Imaging
  • 2017

Prodrugs - Recent approvals and a glimpse of the pipeline.

  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
  • 2017